Rosetta Genomics (ROSG) Sees Large Volume Increase

Rosetta Genomics Ltd. (NASDAQ:ROSG) shares saw an uptick in trading volume on Monday . 874,242 shares traded hands during trading, an increase of 288% from the previous session’s volume of 225,529 shares.The stock last traded at $0.59 and had previously closed at $0.58.

Separately, Barrington Research downgraded shares of Rosetta Genomics from an “outperform” rating to a “market perform” rating in a research report on Monday, December 18th.

The company has a quick ratio of 2.10, a current ratio of 2.10 and a debt-to-equity ratio of 0.03. The firm has a market cap of $3.50, a PE ratio of -0.06 and a beta of 0.32.

COPYRIGHT VIOLATION WARNING: This article was published by Community Financial News and is the property of of Community Financial News. If you are accessing this article on another domain, it was stolen and republished in violation of U.S. and international trademark & copyright legislation. The correct version of this article can be accessed at https://www.com-unik.info/2018/01/22/rosetta-genomics-rosg-sees-large-volume-increase.html.

Rosetta Genomics Company Profile

Rosetta Genomics Ltd. is engaged in developing and commercializing new diagnostic tests based on various genomics markers, including deoxyribonucleic acid (DNA), micro ribonucleic acid (microRNA) and protein biomarkers and using various technologies, including, Quantitative polymerase chain reaction (qPCR), microarrays, Next Generation Sequencing (NGS) and Fluorescence In Situ Hybridization (FISH).

Receive News & Ratings for Rosetta Genomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rosetta Genomics and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit